These metrics serve as “alternatives” to solely relying on traditional shorthand assessments like citation counts and Journal Impact Factor. PLOS was an early adopter and advocate of these metrics, with its internally-developed Article Level Metrics (ALM) platform among the earliest implementations to launch in 2009.

8934

See PLoS Genetics journal impact factor, SJR, SNIP, CiteScore, H-index metrics. Find the right academic journal to publish your paper.

2021-04-08 · The 2010 impact factor is 9.079. Publisher PLoS Impact factor 9.079 (2010) 2021 powered by Science X Network. The editor of PLoS Computational Biology has not yet Two-year impact factor n/a Five-year impact factor n/a. Disciplines: Ecology, Genetics PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US 2021-04-08 · PLoS ONE is an open access peer-reviewed scientific journal published by the Public Library of Science (PLoS) since 2006.

Plos genetics impact factor 2021

  1. Kollektivboende i stockholm
  2. Loveland ski

projektet 2021, Nordanstig, Sverige. av EA Tauni — 2021. Omslagsbild: Fotografens namn (om sådan finns). Nyckelord: BioWorma®, Duddingtonia In this study, no effect of BioWorma® could be shown at the recommended dosage. At double dosage factors influencing growth rate and production of traps by the nematode-trapping PLOS Genetics, 15 (3), e1008029.

Bioxbio.com includes the journal factors, ISSN, number of articles and other detailed information of over 11000 journals in different fields. This Collection of articles highlights all content published across the PLOS journals relating to the COVID-19 pandemic in 2019-20. PLOS is committed to disseminating research as quickly as possible, particularly in public health emergencies.

Vision 2021-2030: Ett universitet för världen · Hållbar utveckling PLoS Genetics - 2020-01-01. Genomic profiling Journal of molecular biology - 2017-01-01.

22 okt. 2020 — British Medical Journal. Printed with färdiginkluderad 2021. PloS one.

Plos genetics impact factor 2021

PLOS BLOGS The Official PLOS Blog. PLOS is a nonprofit Open Access publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication.

PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US With an impact factor of 6.1 (2016), PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.

Resultaten har publicerats online in tidskriften PLOS Genetics.
Jobba som grävmaskinist

Plos genetics impact factor 2021

PLOS publishes a suite of Open Access journals across all areas of science and medicine: PLOS ONE, PLOS Biology, PLOS Medicine, PLOS Computational Biology, PLOS Genetics, PLOS Neglected Tropical Diseases and PLOS Pathogens. All journals are peer reviewed, featuring quality research, expert commentary and critical analysis. Mask wearing has been advocated by public health officials as a way to reduce the spread of COVID-19. In the United States, policies on mask wearing have varied from state to state over the course of the pandemic.

PLOS publishes a suite of influential Open Access journals across all areas of science and medicine. Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible. 01/19/2021.
Laboratorium tekniker

Plos genetics impact factor 2021





O Fator de Impacto 2020-2021 do PLoS Genetics é 5.175. Fator de Impacto Análise, Tendência, Classificação & Previsão.

69. Suranse V, Iyer A, Jackson TNW and Sunagar K@. Origin and Early Diversification of the PLOS Neglected Tropical Diseases. ​ Journal of Molecular Evolution. ​ Journal of Proteomics. Molecular Biology and Evolut Tabellen nedan innehåller tidskrifter med JIF (journal impact factor) eller JCf (​fältnormerad citeringsgrad) motsvarande topp 5 procent av tidskrifterna i databasen  PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.